As of 2025-07-16, the Relative Valuation of Cara Therapeutics Inc (CARA) is (294.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.32 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -5630.9%.
The range of the Relative Valuation is (291.22) - (281.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 18.1x | 17.5x |
| Forward P/E multiples | 18.8x - 22.3x | 20.4x |
| Fair Price | (291.22) - (281.30) | (294.25) |
| Upside | -5574.1% - -5387.5% | -5630.9% |
| Date | P/E |
| 2025-05-09 | -1.65 |
| 2025-05-08 | -1.68 |
| 2025-05-07 | -1.68 |
| 2025-05-06 | -1.69 |
| 2025-05-05 | -1.79 |
| 2025-05-02 | -1.72 |
| 2025-05-01 | -1.64 |
| 2025-04-30 | -1.61 |
| 2025-04-29 | -1.48 |
| 2025-04-28 | -1.36 |
| 2025-04-25 | -1.22 |
| 2025-04-24 | -1.15 |
| 2025-04-23 | -1.19 |
| 2025-04-22 | -1.26 |
| 2025-04-21 | -1.13 |
| 2025-04-17 | -1.10 |
| 2025-04-16 | -1.18 |
| 2025-04-15 | -1.03 |
| 2025-04-14 | -1.07 |